Navigation Links
The American Society for Microbiology honors Frank Leo van de Veerdonk
Date:6/20/2013

Washington, D.C. June 18, 2013 Frank Leo van de Veerdonk, M.D., Ph.D., Nijmegen Medical Centre Radboud University (RUNMC) and Nijmegen Institute for Infection, Inflammation and Immunity (N4i), has received a 2013 ICAAC Young Investigator Award for his work in the field of fungal immunology. Charles Dinarello, University of Colorado, says, "I see Frank as one of the new generation of innovative thinkers in the field of cytokine biology, particularly as it applies to infection."

Van de Veerdonk earned his medical degree in 2001 from the Vrije Universiteit in Amsterdam. He started as a resident in Internal Medicine at Jeroen Bosch Hospital in s' Hertogenbosch under the supervision of Paetrick Netten. In 2006, he continued his training in Internal Medicine at Radboud University in Nijmegen where he was supervised by Jos van der Meer. He began his Ph.D. in 2007, and under the supervision of Mihai Netea, he studied pattern recognition receptors and pathogen associated molecular patterns of Candida albicans and Candida-specific innate and adaptive immune responses. During this time new insights in Th17 biology were discovered and van de Veerdonk found that mutations in STAT1 that lead to gain of function are responsible for autosomal dominant chronic mucocutaneous candidiasis. Mihai Netea, Radboud University Nijmegen, considers this discovery, "a major breakthrough in the diagnosis of immunodeficiencies with fungal infections."

While completing his Ph.D., he worked at St. Jude's Children Research Hospital in the laboratory of Thirumala Kanneganti, where he studied the role of the inflammasome in invasive candidiasis. After receiving a Niels Stensen Stipend in 2010, he went to the University of Colorado to study the role of the new interleukin-1 (IL 1) family members IL-36, IL-37 and IL-38 under the supervision of Charles Dinarello. Dinarello considers van de Veerdonk "a gifted physician/scientist who always has his eye focused on what we can learn from patients." While van de Veerdonk was at the University of Colorado, he discovered that IL-38 binds to the IL-36R and acts similar to IL-36Ra on immune cells. After returning to Nijmegen he finished his Ph.D. and graduated cum laude from Radboud University.

In 2011 van de Veerdonk completed his fellowship in infectious diseases. Then in 2012 he became a faculty member at Radboud University Nijmegen Medical Centre where he works as an internist-infectious diseases specialist. He received a grant from the Nijmegen Centre for Molecular Life Sciences (NCMLS) and a Veni grant from Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) to build his own research group in the laboratory of Mihai Netea and Leo Joosten. Van de Veerdonk is focusing his research on the host defense against Aspergillus and the functional biology of the new IL 1 family members IL-36, IL-37 and IL-38.


'/>"/>

Contact: Garth Hogan
ghogan@asmusa.org
202-942-9389
American Society for Microbiology
Source:Eurekalert

Related biology news :

1. The American Society for Microbiology honors Baligh Yehia
2. The American Society for Microbiology honors George L. Drusano
3. The American Society for Microbiology honors Ken Cadwell
4. American Chemical Society global program tackles safe drinking water in Colombia
5. The American Society for Microbiology honors Marc Torrent
6. The American Society for Microbiology honors Joshua Obar
7. AMP joins the Federation of American Societies for Experimental Biology
8. American Chemical Societys highest honor goes to Stephen J. Lippard, Ph.D.
9. Medicine, energy topics of Kavli lectures at American Chemical Society meeting
10. Save the date: American Chemical Society National Meeting, Sept. 8-12, 2013, in Indianapolis
11. Body mass index of low income African-Americans linked to proximity of fast food restaurants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO ... Diego Rotary Club. The event entitled “Stem Cells and Their Regenerative ... attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program Committee ... honoring scientists who have made outstanding contributions to analytical chemistry and applied ... the world’s leading conference and exposition for laboratory science, which will be held ...
Breaking Biology Technology: